Skip to main content
. 2023 Feb 1;38(5):619–630. doi: 10.1002/jbmr.4765

Table 3.

Univariable associations between baseline characteristics and change in BMD, stratified by HIV status at follow‐up

∆ Lumbar spine BMD (g/cm2) [95%CI] ∆ Total hip BMD (g/cm2) [95% CI] ∆ Total body BMD (g/cm2) [95%CI]
HIV − (n = 385) HIV + (n = 65) HIV − (n = 381) HIV + (n = 62) HIV − (n = 292) HIV + (n = 51)
Sociodemographic and behavioral factors
Age (in decades) −0.009 [−0.027, 0.010] −0.009 [−0.036, 0.017] −0.008 [−0.018, 0.003] −0.001 [−0.023, 0.021] −0.009 [−0.018, −0.001] b −0.022 [−0.049, 0.006]
Finished high school −0.016[−0.038, 0.006] −0.011[−0.041, 0.019] 0.006[−0.006, 0.019] −0.008[−0.033, 0.016] 0.003[−0.007, 0.013] 0.004[−0.028, 0.035]
Currently unemployed −0.001 [−0.023, 0.020] 0.013 [−0.013, 0.038] −0.008 [−0.021, 0.004] 0.019 [−0.001, 0.040] 0.004 [−0.006, 0.014] −0.013 [−0.040, 0.014]
Ever smoked tobacco −0.007 [−0.043, 0.028] 0.015 [−0.028, 0.057] −0.007 [−0.027, 0.013] −0.001 [−0.039, 0.037] 0.006 [−0.010, 0.023] 0.003 [−0.042, 0.047]
Meeting MVPA guidelines (≥150 mins/week) −0.018 [−0.040, 0.004] −0.017 [−0.042, 0.008] −0.010 [−0.022, 0.002] −0.011 [−0.031, 0.010] −0.004 [−0.014, 0.006] −0.018 [−0.044, 0.008]
Women's health
Menopause transition stage
0:Pre‐Pre Ref Ref Ref Ref Ref Ref
1:Pre‐Peri −0.032 [−0.093, 0.030] −0.079 [−0.134, −0.023] b −0.033 [−0.067, 0.001] −0.028 [−0.081, 0.025] −0.025 [−0.055, 0.004] −0.068 [−0.122, −0.015] b
2:Pre‐Post −0.049 [−0.095, −0.003] b −0.069 [−0.105, −0.032] a −0.052 [−0.078, −0.026] a −0.030 [−0.065, 0.006] −0.031 [−0.054, −0.009] b −0.064 [−0.104, −0.024] a
3:Peri‐Peri 0.033 [−0.016, 0.082] −0.009 [−0.045, 0.027] −0.002 [−0.029, 0.026] −0.001 [−0.036, 0.034] −0.003 [−0.027, 0.021] 0.002 [−0.039, 0.043]
4:Peri‐Post −0.037 [−0.085, 0.012] −0.094 [−0.143, −0.045] a −0.038 [−0.065, −0.010] a −0.015 [−0.062, 0.033] −0.041 [−0.064, −0.018] a −0.080 [−0.134, −0.027] b
5:Post‐Post −0.034 [−0.077, 0.008] −0.058 [−0.088, −0.027] a −0.025 [−0.049, −0.001] b −0.025 [−0.055, 0.006] −0.032 [−0.053, −0.011] a −0.053 [−0.086, −0.020] b
Anthropometry and muscle strength
Weight (10 kg) 0.0008 [−0.0059, 0.0077] 0.0041 [−0.0031, 0.0112] 0.0015 [−0.0024, 0.0054] −0.0004 [−0.0062, 0.0055] 0.0008 [−0.0024, 0.0040] 0.0017 [−0.0057, 0.0092]
Height (m) −0.038 [−0.221, 0.145] 0.136 [−0.075, 0.347] −0.056 [−0.159, 0.048] 0.195 [0.027, 0.362] b −0.091 [−0.178, −0.003] b 0.182 [−0.069, 0.433]
Grip strength (kg) −0.001 [−0.004, 0.002] 0.001 [−0.002, 0.003] 0.001 [−0.0002, 0.003] 0.001 [−0.001, 0.003] 0.0004 [−0.001, 0.002] −0.001 [−0.003, 0.002]
DXA fat and lean mass
TBLH fat mass (kg) 0.0001 [−0.001, 0.002] 0.0003 [−0.001, 0.002] 0.0004 [−0.0003, 0.001] −0.0003 [−0.001, 0.001] −0.00001 [−0.001, 0.001] 0.0001 [−0.001, 0.001]
TBLH lean mass (kg) −0.001 [−0.003, 0.001] 0.0002 [−0.002, 0.002] −0.0004 [−0.001, 0.001] −0.0001 [−0.001, 0.001] 0.001 [−0.0001, 0.001] 0.001 [−0.001, 0.002]

Note: Univariable linear regression generating beta coefficients [95% CI] indicating absolute change in BMD (g/cm2) according to baseline characteristics.

Abbreviations: BMD, bone mineral density; HIV, human immunodeficiency virus; MVPA, moderate to vigorous physical activity; TBLH, total body less head.

a

p < 0.001.

b

p < 0.05.